LSA
WST icon

Leonteq Securities AG’s West Pharmaceutical WST Stock Holding History

Leonteq Securities AG’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5K Sell
60
-389
-87% -$119K ﹤0.01% 947
2026
Q1 		$113K Buy
449
+442
+6,314% +$110K ﹤0.01% 704
2025
Q4 		$1.93K Sell
7
-415
-98% -$114K ﹤0.01% 1316
2025
Q3 		$111K Buy
422
+37
+10% +$8.99K ﹤0.01% 723
2025
Q2 		$84.2K Sell
385
-129
-25% -$27.6K ﹤0.01% 746
2025
Q1 		$115K Buy
514
+100
+24% +$27.6K 0.01% 666
2024
Q4 		$136K Buy
414
+413
+41,300% +$130K 0.01% 623
2024
Q3 		$300 Hold
1
– – ﹤0.01% 1157
2024
Q2 		$329 Hold
1
– – ﹤0.01% 1159
2024
Q1 		$396 Sell
1
-500
-100% -$185K ﹤0.01% 1174
2023
Q4 		$176K Buy
501
+50
+11% +$17.7K 0.01% 520
2023
Q3 		$169K Buy
451
+300
+199% +$116K 0.01% 562
2023
Q2 		$57.8K Hold
151
– – ﹤0.01% 802
2023
Q1 		$52.3K Hold
151
– – ﹤0.01% 790
2022
Q4 		$35.5K Hold
151
– – ﹤0.01% 885
2022
Q3 		$37.2K Sell
151
-164
-52% -$50K ﹤0.01% 855
2022
Q2 		$95.2K Buy
315
+165
+110% +$53.7K ﹤0.01% 693
2022
Q1 		$61.6K Buy
+150
New +$58.7K ﹤0.01% 826
2021
Q1 		– Sell
-200
Closed -$56.7K – 1115
2020
Q4 		$56.7K Buy
+200
New +$56.1K ﹤0.01% 761

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Leonteq Securities AG's WST Position: Q2 2026 in Review

Leonteq Securities AG reduced its West Pharmaceutical (WST) stake by 87% in Q2 2026, selling an estimated $119K and leaving 60 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #947.

Leonteq Securities AG first reported a position in WST in Q4 2020 and has held it in 19 quarters since. The position peaked at $176K in Q4 2023. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Leonteq Securities AG held 60 shares of West Pharmaceutical worth $21.5K as of Q2 2026.
  • Leonteq Securities AG sold 389 West Pharmaceutical shares in Q2 2026, an estimated $119K.
  • West Pharmaceutical made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #947 holding.
  • Leonteq Securities AG first reported a position in West Pharmaceutical in Q4 2020 and has held it in 19 quarters since.
  • Leonteq Securities AG's West Pharmaceutical position peaked at $176K in Q4 2023.
  • 827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.